Support for mRNA Vaccine Development

PCMO is equipped with a production line to support the development of mRNA vaccines
to prepare for next pandemic and assist companies.
We have facilities for mRNA synthesis and modification, as well as LNP manufacturing
in conjunction with existing GMP facilities.
Also, We are establishing a system for the production of pre-filled syringe line in addition to Fill&Finish suite.